Nexus ScreenerLYEL stock: Lyell Immunopharma, Inc.
Lyell Immunopharma, Inc. (LYEL) has been one of the market’s top momentum runners on 1 day, most recently November 5, 2026. Here is every run the scanner recorded, the news behind it, and what to check before trading it.
LYEL’s runs
- November 5, 2026+2.2%EarningsLyell Immunopharma: Q3 Earnings Snapshot
Against the price when the scanner flagged it: the regular session’s highest price after the flag, and the 4:00 PM close. Next-day results and the full dilution risk score are in Nexus Pro.
SEC filings to know about
No offering filings or reverse splits from LYEL in the last 30 days.
Offerings and reverse splits often come before a stock falls. The dilution guide explains what to look for; the app scores each stock’s dilution risk from its cash runway and share count.
See LYEL live: chart with VWAP and key levels, float, relative volume, news, filings and alerts when it runs again.
Open LYEL in the appQuestions
How often has LYEL been a top runner?
The Nexus Screener scanner flagged LYEL as a Supernova (up 10% or more on heavy volume) on 1 day since November 5, 2026. It ran 10% or more after being flagged on 0 of 1, with a median high of +2.2% after the flag.
Why did LYEL stock move?
The latest headline recorded when it ran, on November 5, 2026: “Lyell Immunopharma: Q3 Earnings Snapshot”. News is one possible reason; moves can also come from filings, trading activity or the wider market.
Is LYEL a low-float stock?
LYEL has a free float of about 12.1M shares, under the 20M that traders usually call low float, so it can move sharply on heavy volume.